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Stem cell models of human synapse development 
and degeneration
ABSTRACT Many brain disorders exhibit altered synapse formation in development or syn-
apse loss with age. To understand the complexities of human synapse development and 
degeneration, scientists now engineer neurons and brain organoids from human-induced 
pluripotent stem cells (hIPSC). These hIPSC-derived brain models develop both excitatory 
and inhibitory synapses and functional synaptic activity. In this review, we address the ability 
of hIPSC-derived brain models to recapitulate synapse development and insights gained into 
the molecular mechanisms underlying synaptic alterations in neuronal disorders. We also 
discuss the potential for more accurate human brain models to advance our understanding of 
synapse development, degeneration, and therapeutic responses.
ABSTRACT 
INTRODUCTION
In less than a decade, human-induced pluripotent stem cells 
(hIPSCs) have revolutionized research into complex human disorders 
(Dolmetsch and Geschwind, 2011), from neurodevelopmental disor-
ders such as schizophrenia (Brennand et al., 2011; Windrem et al., 
2017), autism (Marchetto et al., 2010, 2017; Krey et al., 2013; Mariani 
et al., 2015; Nestor et al., 2016), and microcephaly (Lancaster et al., 
2013; Qian et al., 2016) to neurodegenerative disorders such as 
Alzheimer’s (Israel et al., 2012; Lin et al., 2018), Parkinson’s (Miller 
et al., 2013; Vera et al., 2016; Prots et al., 2018), and Huntington’s 
(HD iPSC Consortium, 2012; Xu et al., 2017) diseases (Table 1). 
These disorders exhibit altered synapse density and/or morphology 
as demonstrated by both animal models and postmortem patient 
samples (Penzes et al., 2011) and are collectively referred to as 
synaptopathies (Brose et al., 2010). However, the mechanisms that 
underlie synaptic alterations in the human brain are unclear.
hIPSC-derived neurons and brain organoids recapitulate human 
brain development in the laboratory, providing a unique opportunity 
to uncover the dynamic molecular events leading to altered synapse 
formation in neurodevelopmental disorders or synapse loss in neuro-
degeneration. In this review, we discuss how both hIPSC-derived 
two-dimensional (2D) neurons and three-dimensional (3D) brain or-
ganoids develop synapses and synaptic activity that can be used to 
model complex neuronal disorders.1 Each of these models has par-
ticular strengths and challenges for simulating human synapse devel-
opment and degeneration. In general, brain organoids exhibit more 
complexity, whereas hIPSC-derived neurons provide more uniform 
cultures of specific cell types (Kelava and Lancaster, 2016).
Brain organoids recapitulate many aspects of physiological hu-
man brain development. Temporally, brain organoids closely mimic 
human fetal brain development, as revealed by transcriptional anal-
ysis and synaptic development, thus necessitating lengthy culture 
times for functional synapse maturation (Lancaster et al., 2013; 
Mariani et al., 2015; Paşca et al., 2015; Kelava and Lancaster, 2016). 
During prenatal development, excitatory synapses form along the 
dendrite shaft or on filopodia-like projections, but shift to special-
ized dendritic spines postnatally (Yuste and Bonhoeffer, 2004; 
Koleske, 2013). Mature dendritic spines consist of a polarized spine 
neck and head with an electron-dense postsynaptic density (PSD) 
adjacent to a presynaptic axon terminal (Lynch et al., 2007). These 
axospinous synapses have been documented only in brain organ-
oids (Quadrato et al., 2017), although similar investigations are 
needed to determine whether hIPSC-derived neurons exhibit mor-
phological changes associated with excitatory synapse formation 
(Marchetto et al., 2010). Observing the morphological changes as-
sociated with synapse maturation suggests that organoids closely 
mimic human brain development.
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1Throughout the review, hIPSC-derived neurons refer to cultures directed toward 
neuronal differentiation. Most hIPSC-derived neurons are 2D cultures, although 
some are embedded in hydrogels. Brain organoids are also derived from human 
IPSCs, but contain diverse neuroectodermal cells that self-assemble into 3D 
structures.
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In addition to modeling the time course of human brain develop-
ment, brain organoids self-organize into structures that recapitulate 
human brain organization. They develop ventricles with surrounding 
progenitor zones that contain radial glia, and they form deep and 
superficial cortical layers (Lancaster et al., 2013; Paşca et al., 2015). 
Brain organoids also contain astrocytes (Lancaster et al., 2013; Paşca 
et al., 2015; Dezonne et al., 2017; Quadrato et al., 2017; Sloan et al., 
2017). Astrocytes critically support synapse development, mainte-
nance, and function, and are thus important to consider when mod-
eling synaptic disorders (Allen and Eroglu, 2017). In certain cases, 
myelinating oligodendrocytes have also been described in brain or-
ganoids (Di Lullo and Kriegstein, 2017; Madhavan et al., 2018), 
although most myelination occurs postnatally (Miller et al., 2012). 
Organoids also recapitulate biophysical properties of human brain 
development, allowing for events such as cortical folding (Li et al., 
2017; Karzbrun et al., 2018). The 3D matrix of organoids may also 
retain secreted factors that regulate synaptic development and 
degeneration, as suggested by the use of hydrogels to capture 
amyloid plaques in Alzheimer’s human neural cell culture (Choi et al., 
2014, 2016). Thus, brain organoids capture the cellular diversity, 
temporal dynamics, and structural organization of the human brain.
However, depending on the protocol, organoids contain diverse 
ratios of particular cell types. For example, whole-brain organoids 
contain hindbrain, midbrain, forebrain, and even retinal cells (Kelava 
and Lancaster, 2016; Quadrato et al., 2017), whereas hIPSC-derived 
neurons can be directed toward specific lineages and/or enriched 
by fluorescence-analyzed cell sorting. Addition of astrocytes to 
neuronal cultures promotes synapse maturation and spontaneous 
action potential formation. This can be accomplished through 
1) cultures that generate both neurons and astrocytes through a 
shared progenitor, 2) hIPSC-derived neuron-astrocyte cocultures, or 
3) application of astrocyte-conditioned media to hIPSC-derived 
neurons (Tang et al., 2013; Odawara et al., 2016; Gunhanlar et al., 
2018; Xie et al., 2018). Defined cocultures can also be used to 
address how specific cell types contribute to disease progression. 
For example, Down syndrome hIPSC-derived astrocytes compro-
mise synaptogenesis of unaffected hIPSC-derived neurons (Araujo 
et al., 2018). Furthermore, forced expression of neuronal transcrip-
tion factors, either neurogenin-2 or neuroD1, can rapidly induce 
neuronal maturation and functional synaptic activity within 3 wk of 
hIPSC- derived neuron culture (Zhang et al., 2013). Thus, while or-
ganoids enable the study of synapses in a complex environment 
that mimics human fetal brain development, hIPSC-derived neurons 
allow for the enrichment of specific brain cell types and rapid 
induction of physiological maturation (Figure 1).
In this review, we address the ability of both hIPSC-derived neu-
rons and brain organoids to recreate altered synapse development 
and degeneration in the lab,2 which will ultimately enable therapeu-
tic screens for restored synaptic connections. We also discuss 
opportunities for improved hIPSC models that more accurately 
reflect human synaptopathies.
2Unless otherwise noted, the following sections focus on hIPSC-derived 3D 
whole-brain organoids and 2D forebrain cortical neurons (Muratore et al., 2014; 
Brennand et al., 2015; Griesi-Oliveira et al., 2015; Kelava and Lancaster, 2016).
FIGURE 1: Time course of synapse development across hIPSC models. Brain organoids develop synapses and synaptic 
activity similar to those of the human brain. During midfetal gestation (∼18 wk), synapses form and spontaneous activity 
begins (4–6: Tau and Peterson, 2010; Moore et al., 2011; Luhmann et al., 2016). Dendritic spines form postnatally (7,8: 
Yuste and Bonhoeffer, 2004; Koleske, 2013). In both whole-brain organoids (1: Quadrato et al., 2017) and forebrain 
cortical spheroids (Paşca et al., 2015), spontaneous activity begins after ∼4 mo of culture. Furthermore, whole-brain 
organoids exhibit dendritic spines after 8 mo of culture (1: Quadrato et al., 2017). By contrast, hIPSC-derived neurons 
exhibit earlier expression of synaptic markers and spontaneous activity (2: Nadadhur et al., 2017) that can be increased 
by forced expression of neuronal transcription factors (3: Zhang et al., 2013). It is unclear whether hIPSC-derived 
neurons form dendritic spines. The top image is a cryosection of a forebrain cortical spheroid developed according to 
the methods of Paşca et al. (2015), and the bottom image is a 2D hIPSC-derived cortical neuron culture developed 
according to Brennand et al. (2015).
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SYNAPSE DEVELOPMENT
Before hIPSC-derived models were available, research on human 
synapses was limited to a static snapshot of brain development 
available from postmortem tissue. Postmortem studies predomi-
nantly focused on excitatory synapses at dendritic spines, which 
are evident by Golgi staining (Mancuso et al., 2013). Dendritic 
spines are the primary sites of excitatory stimulation leading to 
long-term potentiation and learning and memory formation (Lynch 
et al., 2007). In an immature state, excitatory synapses form be-
tween the presynaptic axon and the dendritic shaft or filopodia-
like spine precursors (Yuste and Bonhoeffer, 2004). Spines then 
mature into a polarized mushroom-shaped structure with a distinct 
head and neck (Yuste and Bonhoeffer, 2004). Glutamate receptors 
cluster at the tip of the spine head in the electron-dense PSD 
(Lynch et al., 2007). In the human prefrontal cortex, excitatory syn-
aptogenesis begins around 18 wk of fetal gestation and coincides 
with spontaneous action potential formation (Tau and Peterson, 
2010; Moore et al., 2011). Early synaptogenesis occurs primarily 
along the dendritic shaft, but shifts to dendritic spines in later peri- 
and postnatal development (Yuste and Bonhoeffer, 2004; Petanjek 
et al., 2011). Excitatory synapses are then either strengthened or 
pruned in an activity-dependent manner throughout childhood, 
leading to relatively stable synapses in adulthood (Penzes et al., 
2011). Conversely, inhibitory synapses suppress action potential 
formation and refine the amount of excitatory synapses (Craig and 
Kang, 2007). Inhibitory synapses form almost exclusively along the 
dendritic shaft and lack the electron-dense PSD and are thus not 
evident by Golgi staining or electron microscopy without the use 
of immunogold labeling. Despite difficulties visualizing inhibitory 
synapses in postmortem tissue, it is known that they critically regu-
late brain development and cognitive function. Disruptions in the 
ratio of excitatory to inhibitory synapses contribute to both neuro-
developmental and neurodegenerative disorders (Penzes et al., 
2011; Gao and Penzes, 2015).
ALTERED SYNAPSE FORMATION IN 
NEURODEVELOPMENTAL DISORDERS
Golgi staining of autism postmortem brain tissue reveals increased 
dendritic spines on cortical pyramidal neurons (Hutsler and Zhang, 
2010; Tang et al., 2014). The observed increase in dendritic spines, 
the primary sites of excitatory neurotransmission, suggests in-
creased excitatory-to-inhibitory signaling in autism (Takarae and 
Sweeney, 2017). This hyperexcitability could account for the in-
creased risk of epilepsy in the autism population (Tuchman and 
Rapin, 2002). However, electroencephalographic data from living 
patients suggest a more complex picture than global hyperexcit-
ability, as autism patient brains exhibit local areas of hyperexcit-
ability balanced by underconnectivity at longer distances (Boutros 
et al., 2015). It is also unclear whether the increased number of 
synapses in autism are functional and stabilized into mature synap-
tic connections or exist as silent synapses without activity. Silent 
synapses may be subject to greater loss, leading to neurodegen-
eration and regression in autism (Hanse et al., 2013; Kern et al., 
2013). It is critical that human brain models capture the lifetime of 
synapse formation, refinement, maintenance, and loss to accu-
rately reflect disease progression.
Unlike in autism, schizophrenia postmortem brains exhibit de-
creased dendritic spines in both the cortex and hippocampus 
(Glantz and Lewis, 2000; Law et al., 2004; Kolomeets et al., 2005; 
Lewis and Sweet, 2009; Sweet et al., 2009). However, decreased 
GABAergic inhibitory signaling in schizophrenia may lead to a 
hyperexcitable state, similar to autism (Gao and Penzes, 2015). 
This further highlights the need for human brain models that cap-
ture the altered development of both excitatory and inhibitory 
synapses to unravel the complexities of neurodevelopmental 
disorders.
STEM CELL MODELS OF SYNAPSE DEVELOPMENT
hIPSC-derived neurons and brain organoids demonstrate a re-
markable ability to mirror human fetal synapse development and 
provide insights into neurodevelopmental pathologies. In both 
models, excitatory synapse formation and spontaneous action 
potentials increase with age similar to the time course of prenatal 
brain development (Shi et al., 2012; Odawara et al., 2016; 
Quadrato et al., 2017) (Figure 1). By 8 mo in culture, brain organ-
oids exhibit excitatory synapses on dendritic spines; reconstruc-
tion of serial-section electron microscopy reveals that 30 out of 37 
synapses formed on dendritic spines (Quadrato et al., 2017). By 
contrast, after 300 d of hIPSC-derived neuron coculture with astro-
cytes, excitatory synapses still primarily form along dendrites and 
soma (Odawara et al., 2016). Notably, the number of synaptophy-
sin-positive excitatory synapses more than doubled between 112 
and 300 d of neuron–astrocyte coculture (Odawara et al., 2016). In 
both hIPSC-derived neurons and brain organoids, spontaneous 
action potentials (spikes) increased with culture time. Spontaneous 
action potentials begin early in development in the absence of a 
stimulus and play important roles in establishing neural circuits 
(Luhmann et al., 2016). At 8 mo, brain organoid spike frequency 
varied from 0 to 6 Hz (mean = 0.66 Hz) (Quadrato et al., 2017). By 
contrast, hIPSC-derived neurons cocultured with astrocytes aver-
aged a spike frequency of ∼2 Hz at 6 wk, which increased to ∼5 Hz 
between 12 and 18 wk and remained constant through 34 wk of 
culture (Odawara et al., 2016). Forced expression of neuronal tran-
scription factors, either neurogenin-2 or NeuroD1, can be used to 
accelerate synapse function, resulting in spontaneous action 
potentials after 3 wk of culture (Zhang et al., 2013). Thus, hIPSC-
derived neurons acquire functional synapses earlier than brain 
organoids, and this activity can be accelerated through forced 
expression of neuronal-specific genes.
hIPSC-derived neurons and brain organoids form specialized 
excitatory and inhibitory synapses. In brain organoids, excitatory 
synapse markers, such as synaptophysin-1 (syn-1) and vesicular glu-
tamate transporter-1 (vGLUT-1), express after 3 mo of culture, while 
the inhibitory presynaptic marker, vesicular GABA Transporter 
(vGAT), expresses at 1 mo of culture (Quadrato et al., 2017). Simi-
larly, in hIPSC-derived neurons, vGAT expression increases at 8 d 
of culture, preceding increased vGLUT-1 expression after 18 d 
(Nadadhur et al., 2017). vGAT expression before glutamatergic 
synapse expression likely reflects the early developmental phe-
nomenon of GABA-induced excitation. GABA-induced excitation 
mediates neuronal migration and the formation of neuronal connec-
tions, while preventing glutamate cytotoxicity in early development 
(Ben-Ari and Tyzio, 2009; Bortone and Polleux, 2009). Later in pre-
natal development, GABA switches from excitation to inhibition 
through expression of the potassium chloride transporter KCC2, 
thus establishing an excitatory-to-inhibitory balance (Bortone and 
Polleux, 2009; Ben-Ari, 2014; Sivakumaran et al., 2015; Leonzino 
et al., 2016). Forebrain organoids exhibit GABA-induced excitation 
and show increased KCC2 expression with longer development 
(84 wk) (Qian et al., 2016). By contrast, GABA-induced excitation 
decreases after 2 wk of hIPSC-derived neuron culture (Rushton 
et al., 2013), providing further support that brain organoids develop 
similarly to the brain in utero, while hIPSC-derived neurons exhibit 
accelerated synapse formation and function.
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STEM CELL MODELS OF SYNAPTIC ALTERATIONS IN 
NEURODEVELOPMENTAL DISORDERS
In addition to recapitulating normal synapse formation and function, 
hIPSC brain models provide insights into the molecular mechanisms 
underlying synaptic abnormalities in neurodevelopmental disor-
ders. Both schizophrenia and autism exhibit synaptic abnormalities 
in the cerebral cortex (Hutsler and Zhang, 2010; Selemon and 
Zecevic, 2015; Ajram et al., 2017). hIPSC-derived neurons from 
schizophrenia patients exhibit reduced neuronal connections and 
decreased RNA expression of excitatory synapse markers, including 
PSD-95 and glutamate receptors, which are rescued by the antipsy-
chotic drug Loxapine (Brennand et al., 2011). In a study of autism 
patients with larger than average head size, hIPSC-derived neurons 
exhibit decreased excitatory synapses and action potentials and 
increased inhibitory synapse markers (Marchetto et al., 2017). Simi-
larly, macrocephaly-associated autism forebrain organoids form 
more inhibitory neurons and synapses (Mariani et al., 2015). These 
results challenge the simplified notion of hyperexcitability in autism, 
particularly for macrocephaly-associated patients. Similarly, hIPSC-
derived neurons from autism patients with Rett syndrome exhibit 
decreased excitatory synapses (Marchetto et al., 2010) but increased 
GABA-induced excitation, which is rescued by KCC2 expression 
(Tang et al., 2016). These results demonstrate how hIPSC-derived 
neurons can reveal patient-specific differences in genetically diverse 
spectrum disorders.
In addition to modeling genetic causes of altered synapse devel-
opment, hIPSC-derived neuronal models can be used to examine 
the impact of environmental factors on neurodevelopment. For ex-
ample, the hormone oxytocin promotes KCC2 expression and the 
shift from GABA-induced excitation to inhibition (Leonzino et al., 
2016). Autism impairs the oxytocin-mediated GABA shift (Ben-Ari, 
2014). Thus, hIPSC brain organoids have the potential to model 
hormone action at the level of synapses and synaptic function. This 
particular feature will be important for addressing how environmen-
tal factors that disrupt hormonal balances contribute to neurodevel-
opmental disorders (Moosa et al., 2018), as well as the potential 
benefits of hormone therapies (DeMayo et al., 2017).
FUTURE ADVANCES IN STEM CELL MODELS OF 
SYNAPSE DEVELOPMENT
Although hIPSC-derived brain models reflect many aspects of hu-
man synapse formation and function, there are opportunities for 
improvement in the areas of synapse development and the model-
ing of neurodevelopmental disorders. One major limitation is the 
heterogeneity of cell types in brain organoids. In matrigel-embed-
ded whole-brain organoids, only 30% of organoids express forebrain 
markers (Quadrato et al., 2017). Because autism and schizophrenia 
primarily affect forebrain regions, whole-brain organoids may not be 
best suited to model certain disorders. Using the matrigel-embed-
ding protocol, it will be necessary to screen and select for specific 
brain regions to compare synapse development in patients and 
typically developing individuals. Alternatively, more recent proto-
cols drive neuronal identity toward specific brain regions, such as 
forebrain cortical spheroids (Paşca et al., 2015) or brain region–
specific organoids cultured in miniature bioreactors (Qian et al., 
2016, 2018). Furthermore, while brain organoids exhibit spontane-
ous network activity, the ability to recreate activity-dependent post-
natal synaptic refinement is needed to address how synapse 
strengthening and/or pruning is altered in neurodevelopmental dis-
orders (Penzes et al., 2011). Recent research demonstrates that the 
activity of photoreceptor cells in brain organoids can be modulated 
with light after 7–9 mo in culture, demonstrating the potential to 
study activity-dependent synaptic refinement (Quadrato et al., 
2017). Additionally, optogenetics can be used to control local and 
global networks of synaptic activity in hIPSC-derived neuronal mod-
els (Klapper et al., 2017). Finally, the recent engraftment of human 
brain organoids into mouse brains (Mansour et al., 2018) provides a 
model to assess how neurodevelopmental disorders affect synapse 
formation and refinement in vivo. hIPSC–animal chimeras may also 
be used to address how altered synapse formation affects behavior, 
similar to research in which schizophrenia hIPSC-derived glial cells 
engrafted into the mouse brain resulted in schizophrenia-like 
behaviors (Windrem et al., 2017).
STEM CELL MODELS OF NEURODEGENERATIVE 
DISEASE
While hIPSC-derived neuronal models reflect neurodevelopmental 
pathology, their developmental stages, which are similar to those of 
the human fetal brain, present a challenge for modeling synapse 
loss in neurodegenerative disorders. hIPSC research shows promise 
for overcoming this challenge and providing insights into the mech-
anisms of synapse loss in neurodegenerative disorders. Synapse 
loss precedes neurodegeneration in Alzheimer’s, Parkinson’s, and 
Huntington’s diseases (Wishart et al., 2006; Koffie et al., 2011; 
Bellucci et al., 2016). Researchers need experimental models to 
observe and manipulate the dynamic molecular events underlying 
synapse loss, especially because animal neurodegenerative models 
can lack key pathological features. For example, mouse models of 
familial Alzheimer’s disease lack tau neurofibrillary tangles (Choi 
et al., 2014). Thus, brain models are needed to capture human-
specific neurodegenerative pathology. These models will allow us to 
address how synapse loss contributes to neurodegeneration and to 
develop therapies for synapse recovery.
In Alzheimer’s disease, neurofibrillary tangles first emerge in the 
cortex and then spread to the hippocampus (Serrano-Pozo et al., 
2011). hIPSC-derived cortical neurons from patients with familial 
and sporadic Alzheimer’s disease exhibit increased amyloid-β 
(Aβ) deposition and phosphorylated tau; however, no differences in 
the density of synapsin-1–positive synapses was observed, and cell 
death was not examined (Israel et al., 2012). In a recent study of 
hIPSC-derived neurons, astrocytes, and microglia-like cells contain-
ing the Alzheimer’s disease–associated APOE4 variant, neurons 
exhibited increased excitatory synapses, while astrocytes and 
microglia showed impaired Aβ clearance (Lin et al., 2018). 
Alzheimer’s disease hIPSC-derived neurons may require enhanced 
aging techniques or insults that trigger neuronal cell death in order 
to study synapse loss in neurodegeneration. For example, growth 
factor withdrawal increases cell death in a Huntington’s disease 
hIPSC model of cortical neurodegeneration (Estrada-Sánchez and 
Rebec, 2013); however, the effect on synapses was not examined 
(Xu et al., 2017). In another example of insult promoting neurode-
generative pathology, α-synuclein oligomers impair axonal trans-
port leading to synaptic degeneration in Parkinson’s disease hIPSC-
derived cortical neurons (Prots et al., 2018). While the cortex is 
affected in Parkinson’s disease, the midbrain, particularly the 
substantia nigra, is the primary site of neurodegeneration (Maiti 
et al., 2017). Telomerase inhibition or progerin-mediated aging of 
Parkinson’s disease hIPSC-derived midbrain dopaminergic neurons 
induces DNA damage, mitochondrial oxidative stress, and dendrite 
degeneration, similar to early stages of Parkinson’s disease (Miller 
et al., 2013; Vera et al., 2016). The use of telomerase inhibition or 
progerin to promote aging-related telomere shortening suggests 
that aging techniques and genetic susceptibility are both necessary 
for using hIPSCs to model neurogenerative disorders.
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ADVANCES IN STEM CELL MODELS OF SYNAPSE 
DEGENERATION
To fully illuminate the mechanisms of synapse loss in neurodegen-
eration, hIPSC models need to incorporate microglia, the brain’s 
resident immune cells. Microglia mediate synapse loss in Alzheimer’s 
disease (Hansen et al., 2017). Because microglia derive from meso-
dermal lineages, rather than neuroectodermal lineages, they have 
been largely overlooked in hIPSC-derived neuronal models (Chan 
et al., 2007). However, recent protocols provide instructions for de-
veloping microglia-like cells from hIPSCs (Abud et al., 2017; Pandya 
et al., 2017), allowing researchers to interrogate how microglia 
shape human synapse formation and loss. Chimeras of patient and 
unaffected control microglia and neurons will help to determine the 
specific contribution of microglia to disease pathology.
Furthermore, transdifferentiation of patient fibroblasts into 
neurons, rather than reprogramming through a stem cell interme-
diate, allows for the preservation of age-related epigenetic profiles 
and shortened telomeres that may more accurately capture neuro-
degenerative pathology (Victor et al., 2018). Transdifferentiated 
medium spiny neurons from adult Huntington’s disease patients 
exhibit huntingtin (HTT) aggregates, DNA damage, mitochondrial 
dysfunction, and neurodegeneration (Victor et al., 2018). While 
transdifferentiated neurons can be engineered into specific neuro-
nal populations, this limited fate currently prevents brain organoid 
generation from transdifferentiation protocols.
CONCLUDING REMARKS
Through the use of hIPSC brain models, we can begin to address 
the fundamental molecular and cellular mechanisms underlying hu-
man neurodevelopment and neurodegeneration. Recent advances 
in hIPSC-derived brain organoids, such as cell-type and brain re-
gion–specific protocols, optogenetics, aging protocols, and hIPSC–
mouse chimeric models will provide even greater insights into the 
mechanisms of synapse formation and loss. As hIPSC-derived 
neurons continue to better model brain disorders, they will be 
powerful tools for drug development and assessment of patient-
specific responses to drug therapies.
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